Biotech

Trillium Reports 2015 Financial and Operating Results

TORONTO, ONTARIO: ...

Imagin Corporate Update: Prototype Development Launched with Boston Management Team

VANCOUVER, BRITISH COLUMBIA: Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting bladder cancer through endoscopes. ...

Theravance Biopharma Announces Positive Results Including Biomarker Data From Phase 1 Study of TD-0714, an Inhibitor of Neprilysin (NEP)

DUBLIN, IRELAND: Study Demonstrates Maximal and Sustained Target Engagement, Low Levels of Renal Elimination and Favorable Safety and Tolerability Profile; Results Support Potential for Once-Daily Dosing With No Dose ...

Flamel Technologies to Present at the 28th Annual ROTH Conference

LYON, FRANCE: ...

Titan Pharmaceuticals to Present at 28th Annual ROTH Conference

SOUTH SAN FRANCISCO, CA: ...

Bioscience Incubators Attract Big Pharma as Bristol-Myers Squibb Offers Startups Cambridge Lab Space, an Industrial Info News Alert

SUGAR LAND, TX: ...

Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2015 Financial Results

SOUTH SAN FRANCISCO, CA: Management Team to Host Conference Call March 15 at 4:15 p.m. ET /1:15 p.m. PT ...

Corbus Pharmaceuticals Expands Clinical Development of Resunab(TM) With Phase 2 Trial for the Treatment of Systemic Lupus Erythematosus

NORWOOD, MA: National Institutes of Health (NIH) to Fund Multicenter Phase 2 SLE Trial ...

Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency

SYDNEY, AUSTRALIA: ...

Theravance Biopharma to Present at Cowen and Company 36th Annual Health Care Conference

DUBLIN, IRELAND: ...